Mar 8, 2024 • 7:30 AM EST XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
Feb 16, 2024 • 8:00 AM EST XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right
Recent Event Mar 11, 2024 • 10:40 am EDT Leerink Partners 2024 Global Biopharma Conference View Event View All